US 11975066
Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 11975066 (Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof) held by SAB Biotherapeutics, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SAB Biotherapeutics, Inc.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K2039/545, A61K2039/55566